
|Articles|June 4, 2007
Latebreakers: OC approved for continuous use
A new birth control pill that is taken daily 365 days a year has received approval. The FDA gave Wyeth the go-ahead for Lybrel, a combination oral contraceptive (OC) that contains 90 mcg levonorgestrel and 20 mcg ethinyl estradiol.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























